Insider sale
KORRO BIO, INC.
$1.51M
108.40K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 108.40K shares of KORRO BIO, INC. valued at approximately $1.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2026ACC: 0001628280-26-044982
10% Owner
Since Nov 2023
108.40K
Shares to sell
$1.51M
Approx. market value
101.58K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Private Placement
Cash
3/23/2023
101.58KTotal acquired101.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/23/2023 | Private Placement Cash | 101.58K | — |
| Total | 101.58K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
580.00
Market value
$8.1K
6/22/2026
—Completed
Units to sell
3.38K
Market value
$47.2K
6/22/2026
—Completed
Units to sell
419.00
Market value
$5.8K
5/28/2026
—Completed
Units to sell
2.44K
Market value
$34.1K
5/28/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
101.58K
Market value
$1.41M
6/23/2026
Total
Units
108.40K
Value
$1.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 580.00 | $8.1K | — | Completed |
6/22/2026 | 3.38K | $47.2K | — | Completed |
5/28/2026 | 419.00 | $5.8K | — | Completed |
5/28/2026 | 2.44K | $34.1K | — | Completed |
| Planned — Approximate Date | ||||
6/23/2026 | 101.58K | $1.41M | Nasdaq | Planned |
| Total | 108.40K | $1.51M | ||